A modified collagen gel dressing promotes angiogenesis in a preclinical swine model of chronic ischemic wounds
Authors:
- 15 September 2014
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 22 (6) , 720-729
Abstract
We recently performed proteomic characterization of a modified collagen gel (MCG) dressing and reported promising effects of the gel in healing full‐thickness excisional wounds. In this work, we test the translational relevance of our aforesaid findings by testing the dressing in a swine model of chronic ischemic wounds recently reported by our laboratory. Full‐thickness excisional wounds were established in the center of bipedicle ischemic skin flaps on the backs of animals. Ischemia was verified by laser Doppler imaging, and MCG was applied to the test group of wounds. Seven days post wounding, macrophage recruitment to the wound was significantly higher in MCG‐treated ischemic wounds. In vitro, MCG up‐regulated expression of Mrc‐1 (a reparative M2 macrophage marker) and induced the expression of anti‐inflammatory cytokine interleukin (IL)‐10 and of fibroblast growth factor‐basic (β‐FGF). An increased expression of CCR2, an M2 macrophage marker, was noted in the macrophages from MCG treated wounds. Furthermore, analyses of wound tissues 7 days post wounding showed up‐regulation of transforming growth factor‐β, vascular endothelial growth factor, von Willebrand's factor, and collagen type I expression in MCG‐treated ischemic wounds. At 21 days post wounding, MCG‐treated ischemic wounds displayed higher abundance of proliferating endothelial cells that formed mature vascular structures and increased blood flow to the wound. Fibroblast count was markedly higher in MCG‐treated ischemic wound‐edge tissue. In addition, MCG‐treated wound‐edge tissues displayed higher abundance of mature collagen with increased collagen type I : III deposition. Taken together, MCG helped mount a more robust inflammatory response that resolved in a timely manner, followed by an enhanced proliferative phase, angiogenic outcome, and postwound tissue remodeling. Findings of the current study warrant clinical testing of MCG in a setting of ischemic chronic wounds.Keywords
Funding Information
- National Institutes of Health (GM077185, GM069589, DK076566)
This publication has 36 references indexed in Scilit:
- Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic woundsProceedings of the National Academy of Sciences, 2010
- Human skin wounds: A major and snowballing threat to public health and the economyWound Repair and Regeneration, 2009
- Alternative Activation of Macrophages: An Immunologic Functional PerspectiveAnnual Review of Immunology, 2009
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Skin regeneration using keratinocytes and dermal fibroblasts cultured on biodegradable microspherical polymer scaffoldsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Role of Inflammatory Mediators in AngiogenesisCurrent Drug Targets - Inflammation & Allergy, 2005
- THE PIG AS A MODEL FOR HUMAN WOUND HEALINGWound Repair and Regeneration, 2001
- Altered collagen metabolism and delayed healing in a novel model of ischemic woundsWound Repair and Regeneration, 1995
- The use of the Picrosirius-polarization method for the study of the biopathology of collagenMemórias do Instituto Oswaldo Cruz, 1991
- Managing ischemic skin ulcers.1975